Dermanolon 1.77 mg/ml + 17.7 mg/ml cutaneous spray, solution for dogs and cats

देश: आयरलैंड

भाषा: अंग्रेज़ी

स्रोत: HPRA (Health Products Regulatory Authority)

सक्रिय संघटक:

Triamcinolone acetonide; Salicylic acid

थमां उपलब्ध:

Le Vet Beheer B.V.

ए.टी.सी कोड:

QD07XB02

INN (इंटरनेशनल नाम):

Triamcinolone acetonide; Salicylic acid

डोज़:

1.77,17.7 milligram(s)/millilitre

फार्मास्यूटिकल फॉर्म:

Cutaneous spray, solution

प्रिस्क्रिप्शन प्रकार:

POM: Prescription Only Medicine as defined in relevant national legislation

चिकित्सीय समूह:

Cats, Dogs

चिकित्सीय क्षेत्र:

triamcinolone

चिकित्सीय संकेत:

Corticosteroid

प्राधिकरण का दर्जा:

Authorised

प्राधिकरण की तारीख:

2017-02-10

उत्पाद विशेषताएं

Health Products Regulatory Authority
14 January 2022
CRN00CDZV
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Dermanolon 1.77 mg/ml + 17.7 mg/ml cutaneous spray, solution for dogs
and cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCES:
​
Triamcinolone acetonide
​
1.77 mg
​
Salicylic acid
​
17.7 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Cutaneous spray, solution.
Clear colourless solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Symptomatic treatment of seborrhoeic dermatitis
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to corticosteroids, salicylic
acid or to any of the excipients
Do not use on cutaneous ulcers.
Do not use in dogs with demodicosis.
Do not administer to animals weighing less than 3.5 kg body weight.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
At the beginning of treatment, existing scale and or exfoliative
debris should be removed. Hair surrounding or covering the
lesions may need to be clipped to enable the veterinary medicinal
product to reach the affected skin.
Seborrhoeic dermatitis may be a primary disorder, but can also occur
as a result of underlying disorders or disease processes
(e.g. allergic disorders, endocrine disorders, neoplasia).
Furthermore, infections (bacterial, parasitic or fungal) commonly
occur
concurrently with seborrhoeic dermatitis. Therefore it is essential to
identify any underlying disease process and initiate specific
treatment if considered necessary.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
As the minimum bodyweight for the treatment is 3.5 kg, this product
will not be suitable for use in certain patients, such as
smaller dogs and cats or those with extensive lesions. Please check
maximum recommended dose in section 4.9.
Systemic corticosteroid effects are possible, especially when the
product is used under an occlusive dressing, on e